The Unregulated Rise of Kratom Drinks: Emerging Challenges and Policy Recommendations

Charoenratana S Anukul C Aramrattana A. Attitudes towards kratom use, decriminalization and the development of a community-based kratom control mechanism in Southern Thailand. Int J Drug Policy. 2021;95:103197. doi:10.1016/j.drugpo.2021.103197.236

Domnic G Narayanan S Mohana-Kumaran N Singh D. Kratom (Mitragyna speciosa Korth.) an overlooked medicinal plant in Malaysia. J Subst Use. 2021;27(1):1-6. doi:10.1080/14659891.2021.1885515

McCurdy CR Sharma A Smith KE , et al. An update on the clinical pharmacology of kratom: uses, abuse potential, and future considerations. Expert Rev Clin Pharmacol. 2024;17(2):131-142. doi:10.1080/17512433.2024.2305798.244

Grundmann O. Patterns of kratom use and health impact in the US—results from an online survey. Drug Alcohol Depend. 2017;176:63-70. doi:10.1016/j.drugalcdep.2017.03.007

Prozialeck WC Jivan JK Andurkar SV. Pharmacology of kratom: an emerging botanical agent with stimulant, analgesic and opioid-like effects. J Am Osteopath Assoc. 2012;112(12):792-799.

Smith KE Lawson T. Prevalence and motivations for kratom use in a sample of substance users enrolled in a residential treatment program. Drug Alcohol Depend. 2017;180:340-348. doi:10.1016/j.drugalcdep.2017.08.034

Swogger MT Walsh Z. Kratom use and mental health: a systematic review. Drug Alcohol Depend. 2018;183:134-140. doi:10.1016/j.drugalcdep.2017.10.012

Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. National Survey on Drug Use and Health Public Use Files, 2021-2023. 2024. Accessed August 20, 2025. https://www.samhsa.gov/data/data-we-collect/nsduh-national-survey-drug-use-and-health/datafiles

Post S Spiller HA Chounthirath T Smith GA. Kratom exposures reported to United States poison control centers: 2011-2017. Clin Toxicol (Phila). 2019;57(10):847-854. doi:10.1080/15563650.2019.1569236

Olsen EO O’Donnell J Mattson CL Schier JG Wilson N. Notes from the field: unintentional drug overdose deaths with kratom detected—27 states, July 2016–December 2017. MMWR Morb Mortal Wkly Rep. 2019;68(14):326-327. doi:10.15585/mmwr.mm6814a2

Striley CW Hoeflich CC Viegas AT , et al. Health effects associated with kratom (Mitragyna speciosa) and polysubstance use: a narrative review. Subst Abuse. 2022;16:11782218221095873. doi:10.1177/11782218221095873

Nolan ML Kunins HV Lall R Paone D. Developing syndromic surveillance to monitor and respond to adverse health events related to psychoactive substance use: methods and applications. Public Health Rep. 2017;132(1 Suppl):65S-72S. doi:10.1177/0033354917718074275

Dietary Supplement Health and Education Act of 1994, Pub L No 103-417, 103rd Cong (1994). Accessed October 9, 2025. https://ods.od.nih.gov/About/DSHEA_Wording.aspx

FDA takes steps to restrict 7-OH opioid products threatening American consumers. News release. US Department of Health and Human Services; July 29, 2025. Accessed August 20, 2025. https://www.hhs.gov/press-room/fda-7-oh-scheduling-recommendation.html

Gummin DD Mowry JB Beuhler MC , et al. 2023 Annual report of the National Poison Data System^® (NPDS) from America’s Poison Centers^®: 41st annual report. Clin Toxicol (Phila). 2024;62(12):793-1027. doi:10.1080/15563650.2024.2412423

Dixson B. He kicked alcohol, became addicted to wellness drink that works like opioid, lawsuit says. Los Angeles Times. April 7, 2023. Accessed July 17, 2025. https://www.latimes.com/california/story/2023-04-07/a-wellness-product-was-advertised-as-an-alternative-to-alcohol-but-hundreds-say-it-ruined-their-lives

Burris S. Where next for opioids and the law? Despair, harm reduction, lawsuits, and regulatory reform. Public Health Rep. 2018;133(1):29-33. doi:10.1177/0033354917743500

Carr D Davis CS Rutkow L. Reducing harm through litigation against opioid manufacturers? Lessons from the tobacco wars. Public Health Rep. 2018;133(2):207-213. doi:10.1177/0033354917751131

Hanson N. 7-Eleven must face liability claims over sales of a drink containing kratom. Courthouse News Service. December 21, 2023. Accessed August 20, 2025. https://www.courthousenews.com/7-eleven-must-face-liability-claims-for-selling-drink-containing-kratom

White CM. Kratom’s use and impact on pediatric populations. J Pediatr Pharmacol Ther. 2025;30(2):289-293. doi:10.5863/1551-6776-30.2.289303

White CM, Belcourt J, Sedensky A. A descriptive assessment of products containing the opioid receptor stimulator mitragynine pseudoindoxyl. Subst Use Misuse. 2025;60(12):1950-1954. doi:10.1080/10826084.2025.2522162

US Food and Drug Administration. Tianeptine products linked to serious harm, overdoses, death. FDA Consumer Updates. Updated May 9, 2025. Accessed August 17, 2025. https://www.fda.gov/consumers/consumer-updates/tianeptine-products-linked-serious-harm-overdoses-death

Edinoff AN Sall S Beckman SP , et al. Tianeptine, an antidepressant with opioid agonist effects: pharmacology and abuse potential, a narrative review. Pain Ther. 2023;12(5):1121-1134. doi:10.1007/s40122-023-00539-5

Vadiei N Evoy KE Grundmann O. The impact of diverse kratom products on use patterns, dependence, and toxicity. Curr Psychiatry Rep. 2025;27(10):584-592. doi:10.1007/s11920-025-01631-7

Nicholls E. “I don’t want to introduce it into new places in my life”: the marketing and consumption of no and low alcohol drinks. Int J Drug Policy. 2023;119:104149. doi:10.1016/j.drugpo.2023.104149

Fernan C Schuldt JP Niederdeppe J. Health halo effects from product titles and nutrient content claims in the context of “protein” bars. Health Commun. 2018;33(12):1425-1433. doi:10.1080/10410236.2017.1358240

Tan ASL Bigman CA. Misinformation about commercial tobacco products on social media—implications and research opportunities for reducing tobacco-related health disparities. Am J Public Health. 2020;110(Suppl 3):S281-S283. doi:10.2105/AJPH.2020.305910

Swogger MT Hart E Erowid F , et al. Experiences of kratom users: a qualitative analysis. J Psychoactive Drugs. 2015;47(5):360-367. doi:10.1080/02791072.2015.1096434

Palamar JJ. Past-year kratom use in the U.S.: estimates from a nationally representative sample. Am J Prev Med. 2021;61(2):240-245. doi:10.1016/j.amepre.2021.02.004

Sharib JR Pomeranz JL Mozaffarian D Cash SB. Disclosure of mandatory and voluntary nutrition labelling information across major online food retailers in the USA. Public Health Nutr. 2024;27(1):e203. doi:10.1017/S1368980024001289344

Bavli I Steel D. Inductive risk and OxyContin: the ethics of evidence and post-market surveillance of pharmaceuticals in Canada. Public Health Ethics. 2020;13(3):300-313. doi:10.1093/phe/phaa017

Dennett JM Gonsalves GS. Early OxyContin marketing linked to long-term spread of infectious diseases associated with injection drug use. Health Aff (Millwood). 2023;42(8):1081-1090. doi:10.1377/hlthaff.2023.00146

Carpenter CM Wayne GF Pauly JL Koh HK Connolly GN. New cigarette brands with flavors that appeal to youth: tobacco marketing strategies. Health Aff (Millwood). 2005;24(6):1601-1610. doi:10.1377/hlthaff.24.6.1601

Perry T Chin S. Kratom drinks and consumption trends: insights from Reddit. J Subst Use. Published online March 24, 2025. doi:10.1080/14659891.2025.2481069

Perry T Chin S . Kratom beverages online: marketing narratives, content, dosing, and potential risks. Subst Use Misuse. Published online November 30, 2025. doi:10.1080/10826084.2025.2592879

Fowble KL Musah RA. A validated method for the quantification of mitragynine in sixteen commercially available kratom (Mitragyna speciosa) products. Forensic Sci Int. 2019;299:195-202. doi:10.1016/j.forsciint.2019.04.009

Hill K Boyer EW Grundmann O Smith KE. De facto opioids: characterization of novel 7-hydroxymitragynine and mitragynine pseudoindoxyl product marketing. Drug Alcohol Depend. 2025;272:112701. doi:10.1016/j.drugalcdep.2025.112701

Dufour J Lin XL Wang J , et al. The safety of multiple-dose liquid blend containing kava and kratom in healthy adults. Cureus. 2024;16(12):e75654. doi:10.7759/cureus.75654

Silveira PD Marreiros C. The influence of advertising at the point-of-purchase on shoppers and brands: an empirical study in convenience stores. Commun Today. 2023;14(1):136-156. doi:10.34135/communicationtoday.2023.Vol.14.No.1.9

Janthongkaw A Klaophimai S Khampaya T , et al. Effect of green and red Thai kratom (Mitragyna speciosa) on pancreatic digestive enzymes (alpha-glucosidase and lipase) and acetyl-carboxylase 1 activity: a possible therapeutic target for obesity prevention. PLoS One. 2023;18(9):e0291738. doi:10.1371/journal.pone.0291738

Trucco EM Fallah-Sohy N Hartmann SA Cristello JV. Electronic cigarette use among youth: understanding unique risks in a vulnerable population. Curr Addict Rep. 2020;7(4):497-508. doi:10.1007/s40429-020-00340-w

Botanic Tonics, maker of feel free, recognized on Bain & Company’s 2025 Insurgent Brands list. News release. EZ Newswire; March 5, 2025. Accessed August 20, 2025. https://www.eznewswire.com/newsroom/botanic-tonics-maker-of-feel-free-recognized-on-bain-company-s-2025-insurgent-brands-list

Rossheim ME LoParco CR Tillett KK Yockey RA Lin HC Berg CJ. Kratom products are widely available throughout the United States. Am J Public Health. 2024;114(11):1188-1190. doi:10.2105/AJPH.2024.307824

Gabay M. The federal Controlled Substances Act: schedules and pharmacy registration. Hosp Pharm. 2013;48(60):473-474. doi:10.1310/hpj4806-473

Popova L Massey ZB Giordano NA. Warning labels as a public health intervention: effects and challenges for tobacco, cannabis, and opioid medications. Annu Rev Public Health. 2024;45(1):425-442. doi:10.1146/annurev-publhealth-060922-042254

Lee HY Lin HC Seo DC Lohrmann DK. The effect of e-cigarette warning labels on college students’ perception of e-cigarettes and intention to use e-cigarettes. Addict Behav. 2018;76:106-112. doi:10.1016/j.addbeh.2017.07.033

Hammond D Reid JL Burkhalter R Rynard VL. E-cigarette marketing regulations and youth vaping: cross-sectional surveys, 2017-2019. Pediatrics. 2020;146(1):e20194020. doi:10.1542/peds.2019-4020

Wildey MB Woodruff SI Agro A Keay KD Kenney EM Conway TL. Sustained effects of educating retailers to reduce cigarette sales to minors. Public Health Rep. 1995;110(5):625-629.

Divino V Cepeda MS Coplan P Maziere JY Yuan Y Wade RL. Assessing the impact of the extended-release/long-acting opioid analgesics risk evaluation and mitigation strategies on opioid prescription volume. J Opioid Manag. 2017;13(3):157-168. doi:10.5055/jom.2017.0383417

Lazard AJ. Social media message designs to educate adolescents about e-cigarettes. J Adolesc Health. 2021;68(1):130-137. doi:10.1016/j.jadohealth.2020.05.030

Rath JM Perks SN Vallone DM , et al. Educating young adults about opioid misuse: evidence from a mass media intervention. Int J Environ Res Public Health. 2021;19(1):22. doi:10.3390/ijerph19010022425